Globant (NYSE:GLOB) has acquired Vertic, a Copenhagen and New York based creative consultancy with a strong focus on life-sciences and other B2B disciplines. This acquisition will allow Globant to consolidate its global digital marketing network and start operations in Denmark from where it will offer services to companies based in the Nordic countries.
Amgen vs. Sandoz: Legal Battle Erupts Over Bone-Strengthening Drug Patents
Amgen Inc (NASDAQ: AMGN) has reportedly sued Novartis AG's (NYSE: NVS) Generic arm Sandoz on proposed versions of its bone-strengthening drugs Prolia and Xgeva containing denosumab, infringing several pa
